Biotricity, Inc. (BTCY) Balance Sheet
BTCY balance sheet, FY2026
March 31, 2026 · U.S. dollars$6.4M assets = $39.4M liabilities + −$33.0M equity
Liabilities exceed assets: shareholders’ equity is negative (−$33.0M).
Both columns are drawn to the same scale: what BTCY owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BTCY financial health
Descriptive bands, not a rating. Fiscal FY2026.
BTCY balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $473,512FY2017 | $6.4MFY2026 | +33.7%/yr | |
| Total liabilities | $4.9MFY2017 | $39.4MFY2026 | +26.2%/yr | |
| Shareholders’ equity | −$4.4MFY2017 | −$33.0MFY2026 | — | |
| Cash & short-term investments | $424,868FY2017 | $149,789FY2026 | −10.9%/yr | |
| Total debt | $1.6MFY2017 | $27.1MFY2026 | +37.3%/yr | |
| Net cash (debt) | −$1.1MFY2017 | −$26.9MFY2026 | −$25.8M | |
| Working capital | −$4.4MFY2017 | −$31.3MFY2026 | −$26.9M | |
| Book value per share | −$1.02FY2017 | −$1.21FY2026 | — | |
| Current ratio | 0.09FY2017 | 0.16FY2026 | +0.07 | |
| Shares outstanding | 4.3MFY2017 | 27.3MFY2026 | +22.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BTCY assets
BTCY liabilities and equity
BTCY debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BTCY balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $149,789 | $365,145 | $786,060 | $570,460 | $12.1M | $2.2M | $949,848 | $63,647 | $843,643 | $424,868 |
| Cash & equivalents | $149,789 | $365,145 | $786,060 | $570,460 | $12.1M | $2.2M | $949,848 | $63,647 | $843,643 | $424,868 |
| Short-term investments | — | — | — | $588,599 | $302,330 | $326,664 | $137,074 | $161,310 | $17,046 | $14,705 |
| Receivables | $2.9M | $2.7M | $1.8M | $1.2M | $2.0M | $1.5M | $486,187 | $369,409 | $17,046 | $15,644 |
| Inventory | $1.3M | $1.6M | $1.9M | $2.3M | $842,924 | $272,493 | $85,720 | $24,604 | −$17,046 | −$14,705 |
| Other current assets | $1.4M | $0 | $0 | $588,599 | $406,280 | $326,664 | $137,074 | $0 | $52,783 | $14,705 |
| Total current assets | $5.9M | $4.6M | $4.5M | $4.7M | $15.3M | $4.3M | $1.7M | $457,660 | $896,426 | $440,512 |
| Property, plant & equipment (net) | $349,860 | $821,652 | $1.2M | $1.6M | $1.3M | $66,120 | $264,472 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $240,144 | $180,010 | $234,907 | $181,344 | $85,000 | $50,358 | $81,115 | $33,000 | $33,000 | $33,000 |
| Total assets | $6.4M | $5.6M | $5.9M | $6.5M | $16.7M | $4.4M | $2.0M | $490,660 | $929,426 | $473,512 |
| Liabilities | ||||||||||
| Accounts payable | $4.4M | $4.6M | $5.2M | $3.4M | $1.2M | $1.0M | $1.1M | $878,453 | $547,858 | $866,188 |
| Short-term debt | $26.2M | $12.6M | $12.1M | $5.1M | $1.8M | $4.3M | $2.3M | $867,699 | — | $1.6M |
| Deferred revenue | $1.6M | $25,322 | $21,550 | $1.6M | $1.4M | −$1.5M | — | — | — | $271,266 |
| Total current liabilities | $37.1M | $20.6M | $22.7M | $11.2M | $4.9M | $10.5M | $3.8M | $2.3M | $756,179 | $4.9M |
| Long-term debt | $870,800 | $13.1M | $10.9M | $13.0M | $12.5M | $370,900 | $0 | $0 | $0 | $0 |
| Lease obligations | $397,830 | $929,116 | $1.4M | $1.7M | $1.3M | $58,257 | $270,085 | — | — | — |
| Other long-term liabilities | $1.4M | $1.9M | $2.4M | $2.1M | $1.5M | $410,042 | $1.2M | $1.7M | $547,858 | $2.4M |
| Total liabilities | $39.4M | $35.7M | $35.9M | $26.4M | $18.8M | $11.3M | $5.0M | $2.3M | $756,179 | $4.9M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $28,759 | $26,243 | $9,515 | $52,514 | $51,277 | $39,015 | $36,382 | $35,362 | $31,858 | $27,199 |
| Retained earnings (deficit) | −$142.6M | −$139.4M | −$127.5M | −$112.6M | −$93.0M | −$62.8M | −$46.4M | −$35.0M | −$26.4M | −$18.3M |
| Accumulated other comprehensive income | $242,727 | $145,792 | $32,378 | −$127,797 | −$768,656 | −$634,186 | −$857,307 | −$754,963 | −$643,129 | −$413,384 |
| Total shareholders' equity | −$33.0M | −$30.0M | −$30.0M | −$19.8M | −$2.1M | −$6.8M | −$3.0M | −$1.8M | $173,247 | −$4.4M |
| Key figures | ||||||||||
| Total debt | $27.1M | $26.1M | $23.9M | $19.5M | $15.4M | $4.7M | $2.3M | $867,699 | — | $1.6M |
| Net cash (debt) | −$26.9M | −$25.7M | −$23.1M | −$19.0M | −$3.3M | −$2.5M | −$1.4M | −$804,052 | — | −$1.1M |
| Working capital | −$31.3M | −$16.0M | −$18.2M | −$6.4M | $10.5M | −$6.2M | −$2.1M | −$1.8M | $140,247 | −$4.4M |
| Tangible book value | −$33.0M | −$30.0M | −$30.0M | −$19.8M | −$2.1M | −$6.8M | −$3.0M | −$1.8M | $173,247 | −$4.4M |
| Book value per share | −$1.21 | −$1.39 | −$3.33 | −$2.29 | −$0.28 | −$1.09 | −$0.50 | −$0.32 | $0.03 | −$1.02 |
| Shares outstanding | 27.3M | 21.5M | 9.0M | 8.7M | 7.6M | 6.3M | 6.0M | 5.6M | 5.0M | 4.3M |
| Current ratio | 0.16 | 0.22 | 0.20 | 0.42 | 3.15 | 0.41 | 0.44 | 0.20 | 1.19 | 0.09 |
| Quick ratio | 0.08 | 0.15 | 0.11 | 0.16 | 2.89 | 0.35 | 0.38 | 0.19 | 1.14 | 0.09 |
| Equity / assets | −511.3% | −532.1% | −504.4% | −304.8% | −12.9% | −154.0% | −149.7% | −362.3% | 18.6% | −926.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $466,503 | $149,789 | $256,357 | $308,460 | $391,292 | $365,145 | $509,601 | $173,270 | $100,731 | $786,060 | $85,094 | $1.2M |
| Cash & equivalents | $466,503 | $149,789 | $256,357 | $308,460 | $391,292 | $365,145 | $509,601 | $173,270 | $100,731 | $786,060 | $85,094 | $1.2M |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | $224,895 | $240,211 |
| Receivables | $2.4M | $2.9M | $1.6M | $3.0M | $3.0M | $1.7M | $2.8M | $2.1M | $1.5M | $1.8M | $1.6M | $1.6M |
| Inventory | $1.4M | $1.3M | $2.0M | $2.3M | $1.8M | $1.6M | $1.6M | $1.8M | $1.9M | $1.9M | $2.0M | $2.1M |
| Other current assets | $1.3M | $1.4M | $1.2M | $0 | $0 | $1.1M | $0 | $0 | $562,245 | $0 | $224,896 | $240,211 |
| Total current assets | $5.6M | $5.9M | $5.0M | $5.5M | $5.1M | $4.6M | $4.9M | $4.1M | $4.1M | $4.5M | $3.9M | $5.2M |
| Property, plant & equipment (net) | $222,069 | $349,860 | $473,561 | $593,302 | $709,294 | $821,652 | $930,481 | $1.0M | $1.1M | $1.2M | $1.3M | $1.4M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $205,399 | $240,144 | $231,695 | $193,236 | $183,485 | $180,010 | $195,579 | $191,671 | $188,494 | $234,907 | $220,560 | $217,930 |
| Total assets | $6.0M | $6.4M | $5.7M | $6.3M | $6.0M | $5.6M | $6.0M | $5.3M | $5.4M | $5.9M | $5.5M | $6.8M |
| Liabilities | ||||||||||||
| Accounts payable | $4.6M | $4.4M | $4.8M | $4.7M | $4.7M | $4.6M | $4.6M | $4.8M | $4.8M | $5.2M | $4.7M | $4.5M |
| Short-term debt | $26.1M | — | $14.1M | $13.4M | $13.0M | — | $12.3M | $12.0M | $12.0M | $12.1M | $10.1M | $8.3M |
| Deferred revenue | $1.5M | — | $779,457 | $1.9M | $475,575 | — | $24,252 | $24,252 | $79,013 | $21,550 | $11,040 | $8,750 |
| Total current liabilities | $37.3M | $37.1M | $23.8M | $23.6M | $21.8M | $20.6M | $21.1M | $21.5M | $20.6M | $22.7M | $18.6M | $17.8M |
| Long-term debt | $870,800 | $870,800 | $13.0M | $12.9M | $13.3M | $13.1M | $12.6M | $10.4M | $10.3M | $10.9M | $11.4M | $12.0M |
| Lease obligations | $252,172 | $397,830 | $539,398 | $674,013 | $803,380 | $929,116 | $1.1M | $1.2M | $1.3M | $1.4M | $1.5M | $1.5M |
| Other long-term liabilities | $1.5M | $1.4M | $1.4M | $1.5M | $1.7M | $1.9M | $2.0M | $2.3M | $2.1M | $2.4M | $2.2M | $2.5M |
| Total liabilities | $39.7M | $39.4M | $38.2M | $38.0M | $36.8M | $35.7M | $35.8M | $34.2M | $33.0M | $35.9M | $32.2M | $32.3M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $20,237 | — | $27,969 | $26,953 | $26,729 | — | $24,556 | $23,024 | $21,645 | $9,515 | $9,420 | $8,811 |
| Retained earnings (deficit) | −$143.6M | −$142.6M | −$142.1M | −$141.0M | −$140.2M | −$139.4M | −$137.4M | −$136.1M | −$134.4M | −$127.5M | −$123.1M | −$120.1M |
| Accumulated other comprehensive income | $237,910 | — | −$47,823 | −$33,276 | $109,623 | — | $3,265 | −$73,415 | $55,961 | $32,378 | −$226,889 | −$47,387 |
| Total shareholders' equity | −$33.7M | −$33.0M | −$32.5M | −$31.7M | −$30.8M | −$30.0M | −$29.8M | −$28.9M | −$27.6M | −$30.0M | −$26.7M | −$25.5M |
| Key figures | ||||||||||||
| Total debt | $26.9M | $870,800 | $27.1M | $26.4M | $26.6M | $13.1M | $25.5M | $23.0M | $23.1M | $23.9M | $22.6M | $21.4M |
| Net cash (debt) | −$26.5M | −$721,011 | −$26.8M | −$26.0M | −$26.2M | −$12.8M | −$24.9M | −$22.8M | −$23.0M | −$23.1M | −$22.5M | −$20.2M |
| Working capital | −$31.7M | −$31.3M | −$18.8M | −$18.1M | −$16.7M | −$16.0M | −$16.3M | −$17.4M | −$16.5M | −$18.2M | −$14.7M | −$12.6M |
| Tangible book value | −$33.7M | −$33.0M | −$32.5M | −$31.7M | −$30.8M | −$30.0M | −$29.8M | −$28.9M | −$27.6M | −$30.0M | −$26.7M | −$25.5M |
| Book value per share | −$1.46 | −$1.15 | −$1.18 | −$1.20 | −$1.17 | −$1.14 | −$1.23 | −$1.28 | −$1.95 | −$3.15 | −$2.98 | −$2.90 |
| Shares outstanding | 23.1M | 28.8M | 27.6M | 26.3M | 26.3M | 26.2M | 24.2M | 22.5M | 14.2M | 9.5M | 9.0M | 8.8M |
| Current ratio | 0.15 | 0.16 | 0.21 | 0.23 | 0.24 | 0.22 | 0.23 | 0.19 | 0.20 | 0.20 | 0.21 | 0.29 |
| Quick ratio | 0.08 | 0.08 | 0.08 | 0.14 | 0.15 | 0.10 | 0.16 | 0.10 | 0.08 | 0.11 | 0.09 | 0.16 |
| Equity / assets | −559.3% | −511.3% | −571.9% | −500.8% | −510.1% | −532.1% | −497.6% | −545.7% | −509.0% | −504.4% | −487.2% | −373.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed July 14, 2026); data from EODHD.
BTCY financial position
At the end of fiscal 2026 (March 31, 2026), Biotricity had total assets of $6.4 million (up 14.3% from a year earlier), total liabilities of $39.4 million and shareholders' equity of -$33.0 million. It held $0.1 million in cash and short-term investments against $27.1 million of debt, net debt of $26.9 million. Its current ratio was 0.16. In the latest quarter (ended June 30, 2026) total assets were $6.0 million and equity -$33.7 million.
Related: BTCY income statement, BTCY cash flow statement, BTCY key metrics. See the BTCY stock overview for the latest quote and news.
BTCY balance sheet FAQ
What are Biotricity's total assets?
Biotricity reported total assets of $6.4 million at the end of fiscal 2026 (March 31, 2026), compared with $5.6 million a year earlier.
How much debt does Biotricity have?
Biotricity had $27.1 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does Biotricity have?
Biotricity held $0.1 million in cash and short-term investments at the end of fiscal 2026; with $27.1 million of debt that is net debt of $26.9 million.
What is Biotricity's book value?
Biotricity's shareholders' equity (book value) was -$33.0 million at the end of fiscal 2026, or −$1.21 per share.
What is Biotricity's current ratio?
Biotricity had current assets of $5.9 million and current liabilities of $37.1 million, a current ratio of 0.16 (current liabilities exceed current assets).